PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
UnitedHealthcareMedicaid · Billing Codes · Medical Benefit Drug Policy · TN · Allergy & Immunology, PharmacyMedium impact

Omalizumab

Effective date
Dec 1, 2026
Identified
Nov 7, 2026

Summary

Effective 2026-12-01, UnitedHealthcare's Community Plan of Tennessee Medicaid policy for omalizumab is retitled from Xolair to omalizumab and now covers Omlyclo (omalizumab-igec), Xolair, and any FDA-approved, launched omalizumab biosimilar not named in the policy, with unlisted biosimilars treated as non-preferred until UnitedHealthcare reviews them. Omalizumab for healthcare-professional-administered subcutaneous injection falls under this medical benefit policy, while self-administered omalizumab is obtained under the pharmacy benefit, and HCPCS code Q5154 has been added.

Get alerts when payers change rules like this one

We check UnitedHealthcare and other payers every day and email you when a change matches your specialty and state.

Get UnitedHealthcare alertsPolicy Monitoring is free. No card required.

What to do

Action · 3 steps
01By 2026-12-01: Billing team should add HCPCS Q5154 to the charge master and charge entry for omalizumab products administered in the office, and update the claim edits so omalizumab claims for Tennessee Medicaid members are billed with the correct product code.
02Providers and front desk staff should be told that only in-office healthcare-professional-administered omalizumab is billed under this medical benefit, while self-administered omalizumab must be routed to the pharmacy benefit.
03Billing team should update the payer-specific product reference in the practice's workflow so that Omlyclo, Xolair, and biosimilars are each recorded by their exact product name, and watch for UnitedHealthcare's review of unlisted biosimilars, since claims for products not yet reviewed will be treated as non-preferred.

Codes mentioned

Q5154

Original notice

Omalizumab
uhcprovider.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account